Inventor · disambiguated record
Lin Zhang
Also filed as: ZHANG LIN · ZHANG LIN-HUA
46 granted patents·38 pending applications·1,153 citations·filing 1993–2024
98Inventor score
Files withCONFORMA THERAPEUTICS CORP8BOEHRINGER INGELHEIM PHARMA7BEIJING JITAI PHARMACEUTICAL TECH CO LTD6LIGAND PHARM INC4DU PONT PHARM CO3
Top patents by PatentIndex Score
84 records- 0196US6583282B1Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Jun 24, 2003·72 cites·9 claims
- 0296US6319921B1Aromatic heterocyclic compound as antiinflammatory agentsBOERHRINGER INGELHEIM PHARMACEUTICALS INC·Filed 2000·Granted Nov 20, 2001·198 cites·19 claims
- 0395US7138401B22-aminopurine analogs having HSP90-inhibiting activityCONFORMA THERAPEUTICS CORP·Filed 2004·Granted Nov 21, 2006·60 cites·46 claims
- 0495US6746845B2Method for serial analysis of gene expressionUNIV JOHNS HOPKINS·Filed 2002·Granted Jun 8, 2004·43 cites·11 claims
- 0595US5695937AMethod for serial analysis of gene expressionUNIV JOHNS HOPKINS MED·Filed 1995·Granted Dec 9, 1997·218 cites·43 claims
- 0694US6894173B2Intermediates useful for synthesis of heteroaryl-substituted urea compounds, and processes of making sameBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted May 17, 2005·48 cites·8 claims
- 0793US7241890B2Purine analogs having HSP90-inhibiting activityCONFORMA THERAPEUTICS CORP·Filed 2002·Granted Jul 10, 2007·93 cites·5 claims
- 0892US6242453B1Polycyclo heterocyclic derivatives as antiinflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Jun 5, 2001·53 cites·18 claims
- 0989US5866330AMethod for serial analysis of gene expressionUNIV JOHNS HOPKINS MED·Filed 1995·Granted Feb 2, 1999·113 cites·44 claims
- 1089US5721103ATrienoic retinoid compounds and methodsLIGAND PHARM INC·Filed 1995·Granted Feb 24, 1998·35 cites·39 claims
- 1187US6333325B1Method of treating cytokine mediated diseases or conditionsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Dec 25, 2001·21 cites·6 claims
- 1283US7465718B2Ansamycins having improved pharmacological and biological propertiesCONFORMA THERAPEUTICS CORP·Filed 2003·Granted Dec 16, 2008·27 cites·23 claims
- 1383US6753426B2Polymorph and process for preparing sameBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Jun 22, 2004·12 cites·2 claims
- 1482US11040954B1CXCR3 receptor agonistsRECEPTOS LLC·Filed 2020·Granted Jun 22, 2021·2 cites·36 claims
- 1581US6083977ATrienoic retinoid compounds and methodsLIGAND PHARM INC·Filed 1995·Granted Jul 4, 2000·20 cites·37 claims
- 1680US5998654ARetinoic acid receptor antagonist compounds and methodsLIGAND PHARM INC·Filed 1997·Granted Dec 7, 1999·21 cites·29 claims
- 1779US6383743B1Method for serial analysis of gene expressionUNIV JOHNS HOPKINS·Filed 1998·Granted May 7, 2002·49 cites·23 claims
- 1872US2024390401A1Combination of bcl-2/bcl-xl inhibitors and chemotherapeutic agent and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 1971US10280436B2Site-specific integrationLONZA BIOLOGICS PLC·Filed 2013·Granted May 7, 2019·1 cites·20 claims
- 2069US9890149B2Isothiazole derivatives as CFTR modulatorsNuBridge BioSciences·Filed 2016·Granted Feb 13, 2018·1 cites·15 claims
- 2169US7385063B2Method for preparing imidazole derivativesCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Jun 10, 2008·5 cites·12 claims
- 2269US6774233B2Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Aug 10, 2004·2 cites·9 claims
- 2367US12083136B2Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Sep 10, 2024·0 cites·4 claims
- 2466US12246308B2Catalyst including molecular sieve having topological pore structure, preparation method therefor and use thereofCHINA PETROLEUM & CHEM CORP·Filed 2021·Granted Mar 11, 2025·0 cites·17 claims
- 2566US7524969B2Malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Apr 28, 2009·3 cites·5 claims
- 2666US6545049B1Dimer-selective RXR modulators and methods for their useLIGAND PHARM INC·Filed 1999·Granted Apr 8, 2003·22 cites·36 claims
- 2765US2025161482A1Rapidly metabolized lipid compoundBEIJING JITAI PHARMACEUTICAL TECH CO LTD·Filed 2024·Application pending·0 cites
- 2865US2024327496A1Improved Expression Vectors and Uses ThereofPFIZER·Filed 2022·Application pending·0 cites
- 2964US2024174727A1Long-acting natriuretic peptides and uses thereofLILLY CO ELI·Filed 2023·Application pending·0 cites
- 3063US11326185B2Site-specific integrationLONZA BIOLOGICS PLC·Filed 2018·Granted May 10, 2022·0 cites·11 claims
- 3163US6333152B1Gene expression profiles in normal and cancer cellsUNIV JOHNS HOPKINS·Filed 1998·Granted Dec 25, 2001·24 cites·19 claims
- 3261US2025026713A1Rapidly metabolized lipid compoundBEIJING JITAI PHARMACEUTICAL TECH CO LTD·Filed 2024·Application pending·0 cites
- 3361US2007185064A12-Aminopurine Analogs Having HSP90-Inhibiting ActivityCONFORMA THERAPEUTICS CORP·Filed 2006·Application pending·0 cites
- 3460US9920094B2Affinity peptide ligand of mouse polyoma virus capsomer and designed screening method thereofUNIV TIANJIN·Filed 2014·Granted Mar 20, 2018·1 cites·11 claims
- 3560US2023287455A1Cells Having Gene Duplications and Uses ThereofPFIZER·Filed 2021·Application pending·0 cites
- 3658US2024316163A1Application of Lactoferrin in Prevention and Treatment of Alzheimer's DiseaseUNIV SICHUAN·Filed 2022·Application pending·0 cites
- 3756US6835832B2Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Dec 28, 2004·0 cites·7 claims
- 3856US2024245782A1Ionizable lipid compoundsBEIJING JITAI PHARMACEUTICAL TECH CO LTD·Filed 2024·Application pending·0 cites
- 3955US8119819B2Malonyl-CoA decarboxylase inhibitors useful as metabolic modulatorsARRHENIUS THOMAS·Filed 2009·Granted Feb 21, 2012·0 cites·4 claims
- 4055US2022008561A1Bismuth metal-organic frameworks for use as x-ray computed tomography contrast agentsUNIV NORTHWESTERN·Filed 2019·Application pending·0 cites
- 4154US2024026457A1Application of variations in notch family genes in predicting sensitivity to immune checkpoint inhibitor therapy in patients with solid tumorsSHANGHAI ORIGIMED CO LTD·Filed 2021·Application pending·0 cites
- 4253US12162819B2Ionizable lipid compoundsBEIJING JITAI PHARMACEUTICAL TECH CO LTD·Filed 2023·Granted Dec 10, 2024·0 cites·25 claims
- 4353US2008318338A1Assays and Implements for Determining and Modulating HSP90 Binding ActivityCONFORMA THERAPEUTICS CORP·Filed 2008·Application pending·0 cites
- 4453US2002058678A1Aromatic heterocyclic compounds as antiinflammatory agentsFiled 2001·Application pending·0 cites
- 4552US2023375548A1Indirect enzyme-linked immunosorbent assay detection kit based on p30 protein and p22 protein of african swine fever virusINST ANIMAL SCIENCE & VETERINARY MEDICINE SHANDONG AAS·Filed 2023·Application pending·0 cites
- 4652US2024245617A1Lipid-based topical injection formulationsBEIJING JITAI PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 4752US2008125446A1Purine analogs having HSP90-inhibiting activityCONFORMA THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 4851US10251854B2S-(carboxymethyl)-cysteine pharmaceutical compound and preparation method and use thereofGUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY·Filed 2013·Granted Apr 9, 2019·0 cites·10 claims
- 4951US2023346702A1Lipid nanoparticlesBEIJING JITAI PHARMACEUTICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 5050US12358913B2Crystal of diarylthiohydantoin compoundCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Jul 15, 2025·0 cites·9 claims
Showing the top 50 of 84 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lin Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →